JPS5850986B2 - Lysine derivative - Google Patents
Lysine derivativeInfo
- Publication number
- JPS5850986B2 JPS5850986B2 JP12887377A JP12887377A JPS5850986B2 JP S5850986 B2 JPS5850986 B2 JP S5850986B2 JP 12887377 A JP12887377 A JP 12887377A JP 12887377 A JP12887377 A JP 12887377A JP S5850986 B2 JPS5850986 B2 JP S5850986B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- enzyme
- ester
- phenol
- lysine derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000002668 lysine derivatives Chemical class 0.000 title claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 40
- 102000004190 Enzymes Human genes 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 27
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 24
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 claims description 20
- 230000000694 effects Effects 0.000 claims description 20
- 239000000758 substrate Substances 0.000 claims description 15
- -1 α-naphthyl Chemical group 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 238000006482 condensation reaction Methods 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000006242 amine protecting group Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 36
- 239000000243 solution Substances 0.000 description 20
- 150000002148 esters Chemical class 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 7
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000012588 trypsin Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HIMZZLFXYJQVGJ-LBPRGKRZSA-N (2s)-6-amino-2-[(4-methylphenyl)sulfonylamino]hexanoic acid Chemical class CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(O)=O)C=C1 HIMZZLFXYJQVGJ-LBPRGKRZSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 108010028774 Complement C1 Proteins 0.000 description 1
- 102100025406 Complement C1s subcomponent Human genes 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical class [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical group OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FKMJXALNHKIDOD-LBPRGKRZSA-N TAMe Chemical compound NC(=N)NCCC[C@@H](C(=O)OC)NS(=O)(=O)C1=CC=C(C)C=C1 FKMJXALNHKIDOD-LBPRGKRZSA-N 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- MNZMECMQTYGSOI-UHFFFAOYSA-N acetic acid;hydron;bromide Chemical compound Br.CC(O)=O MNZMECMQTYGSOI-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 244000245420 ail Species 0.000 description 1
- 238000006149 azo coupling reaction Methods 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は式(I)で示されるリジン誘導体、その製造法
、及びその化合物を基質として酵素活性を測定する方法
に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a lysine derivative represented by formula (I), a method for producing the same, and a method for measuring enzyme activity using the compound as a substrate.
式中、Rはフェニル基またはα−ナフチル基を示す。In the formula, R represents a phenyl group or an α-naphthyl group.
)本発明物
質(I)は新規な化合物であり、酵素活性を測定する為
の試験薬として有用な化合物である。) The substance (I) of the present invention is a novel compound and is a compound useful as a test drug for measuring enzyme activity.
本発明物質(I)はN−トシルリジン誘導体(II)と
フェノール又はα−ナフトールとの通常の脱水縮合反応
により式(I)で示されるエステル体とし、次いでω−
アミノ基保護基を除去することにより製造することがで
きる。The substance (I) of the present invention is formed into an ester body represented by the formula (I) by a conventional dehydration condensation reaction between the N-tosyllisine derivative (II) and phenol or α-naphthol, and then ω-
It can be produced by removing the amino group protecting group.
式中、Rはフェニル基またはα−ナフチル基を示す。In the formula, R represents a phenyl group or an α-naphthyl group.
R′はアミノ基保護基を示す。本発明を実施するに当っ
ては、上記N−トシルリジン誘導体(II)とフェノー
ル又はα−ナフトールとの通常の脱水縮合反応によって
エステル体(II)を得ることができる。R' represents an amino group-protecting group. In carrying out the present invention, the ester (II) can be obtained by a conventional dehydration condensation reaction between the above N-tosyllysine derivative (II) and phenol or α-naphthol.
すなわち、N−トシルリジン誘導体を適当な溶媒に溶解
し、DCC(ジシクロへキシルカーポジイミド)、DP
PA(ジフェニルフォスフォリルアシト)、クロル炭酸
アルキル等のエステル活性化剤を加えこれにフェノール
又はα−ナフトールを加え、必要に応じトリエチルアミ
ン等の塩基を加え、撹拌することにより製造することが
できる。That is, an N-tosyl lysine derivative is dissolved in a suitable solvent, DCC (dicyclohexylcarposiimide), DP
It can be produced by adding an ester activator such as PA (diphenylphosphorylaceto) or alkyl chlorocarbonate, adding phenol or α-naphthol thereto, adding a base such as triethylamine if necessary, and stirring.
又、良く知られた酸クロライド法や、フェノール又はα
−ナフトールのスルフイツト体としてよく知られたフェ
ニル化剤又はαナフチル化剤(Ber、49,2339
,1916)を用いることによっても製造することがで
きる。In addition, the well-known acid chloride method, phenol or α
- Phenylating agent or α-naphthylating agent (Ber, 49, 2339), which is well known as the sulfite form of naphthol.
, 1916).
使用し得る溶媒は、クロロホルム、ジクロルメタン、ジ
メチルホルムアミド、テトラヒドロフラン等通常使用さ
れるもので、原料物質を溶解するものであれば良い。Usable solvents include commonly used solvents such as chloroform, dichloromethane, dimethylformamide, and tetrahydrofuran, as long as they can dissolve the raw material.
反応温度は0°〜40℃で良い。反応終了後、通常行わ
れる処理方法により、反応液よりエステル体(l[)を
得ることができる。The reaction temperature may be 0° to 40°C. After the reaction is completed, the ester (l[) can be obtained from the reaction solution by a commonly used treatment method.
すなわち、例えばDCCを縮合剤として製造した場合、
析出するジシクロヘキシル尿素を流域して除き、塩酸水
溶液、NaOH水溶液、及び飽和食塩水で洗浄し、無水
硫酸マグネシウム等の乾燥剤で乾燥後、溶媒を留去する
ことにより得ることができる。That is, for example, when DCC is produced as a condensing agent,
It can be obtained by removing the precipitated dicyclohexyl urea, washing with an aqueous hydrochloric acid solution, an aqueous NaOH solution, and a saturated saline solution, drying with a desiccant such as anhydrous magnesium sulfate, and then distilling off the solvent.
エステル体(1)は所望により、再結晶、クロマトグラ
フィー等により精製することができる。Ester (1) can be purified by recrystallization, chromatography, etc., if desired.
エステル体(I)より目的化合物(1)を製造する場合
のアミノ基保護基を除去する通常の反応で得ることがで
きる。It can be obtained by a usual reaction in which the amino group protecting group is removed when producing the target compound (1) from the ester (I).
すなわち、例えばアミノ基保護基がカルボベンジルオキ
シ基の場合、(■)を適当な溶媒に溶解しパラジウム炭
素等の触媒で還元的に除去するか、(■)を臭化水素酸
酢酸溶液に加え析出する目的化合物の臭化水素酸塩を流
域することにより得ることができる。That is, for example, when the amino group-protecting group is a carbobenzyloxy group, (■) is dissolved in a suitable solvent and removed reductively with a catalyst such as palladium on carbon, or (■) is added to a hydrobromide and acetic acid solution. It can be obtained by flowing the precipitated hydrobromide of the target compound.
本発明物質(I)は、酵素と接触させることにより基質
として働き、一定時間抜酵素により水解されて遊離した
フェノール、又はα−ナフトールを測定することにより
、酵素の活性を測定することが出来る。The substance (I) of the present invention acts as a substrate when brought into contact with an enzyme, and the activity of the enzyme can be measured by measuring the phenol or α-naphthol released after being hydrolyzed by enzyme removal for a certain period of time.
酵素の活性を測定するということは酵素製剤の規格、血
中酵素パターンの測定による診断、血中酵素濃度の測定
等の為に非常に重要なことである。Measuring enzyme activity is very important for purposes such as standardization of enzyme preparations, diagnosis by measuring blood enzyme patterns, and measurement of blood enzyme concentration.
従来、酵素活性を測定するためには種々の方法が知られ
ている。Conventionally, various methods are known for measuring enzyme activity.
その一つの方法として、アミノ酸のアルキルエステルを
基質として、酵素と接触させ、そのエステルの氷解の程
度により活性を測定するという方法がある。One method is to use an alkyl ester of an amino acid as a substrate, contact it with an enzyme, and measure the activity based on the degree of thawing of the ester.
例えば、ヘステリン法として良く知られている方法がそ
の一つである。For example, a method well known as the Hesterin method is one of them.
これは、酵素とアミノ酸のアルキルエステルを接触させ
、一定時間後に残存するエステル部分をヒドロキシルア
ミンによりヒドロキサム酸とし、過りロル鉄と反応させ
発色させ、その発色を吸光度として測定し、その結果よ
り、酵素のエステル氷解能、すなわち、酵素の活性を測
定するという方法である。This is done by bringing an enzyme into contact with an alkyl ester of an amino acid, converting the remaining ester moiety after a certain period of time into hydroxamic acid with hydroxylamine, reacting with ferrous iron to develop a color, and measuring the color development as absorbance. Based on the results, This method measures the ester ice-melting ability of an enzyme, that is, the activity of the enzyme.
その他、基質を用いエステルの氷解能を指標とする方法
には、クロモトロブ酸法などがあるが、これらの方法で
は、ある程度の酵素量を必要とし、酵素が低濃度である
場合、又は低活性の酵素の測、定には難があった。Other methods that use a substrate and use the ice-melting ability of esters as an indicator include the chromotrobic acid method, but these methods require a certain amount of enzyme and are difficult to use when the enzyme is at a low concentration or has low activity. There were difficulties in measuring and determining enzymes.
そこで、発明者は、酵素に対してアフイニテイを持ち、
更に定量法が簡便であり、かつ検出感度の良いという三
つの条件を兼ね備えた基質としての化合物を検索するこ
とにより従来よりも、非常に優れた化合物を見出すこと
ができた。Therefore, the inventor has an affinity for enzymes,
Furthermore, by searching for compounds that can serve as substrates that meet the following three conditions: simple quantitative method and high detection sensitivity, we were able to find a compound that is far superior to conventional methods.
本発明を実施するに当っては、酵素と一定量の化合物(
1)を、適当な緩衝液中で接触させ、一定温度で、一定
時間後に遊離したフェノール、又はαナフトールを測定
することにより、酵素の活性を測定することができる。In carrying out the present invention, an enzyme and a certain amount of a compound (
Enzyme activity can be measured by contacting 1) in an appropriate buffer solution and measuring liberated phenol or α-naphthol after a certain period of time at a certain temperature.
緩衝液はその酵素の至滴pHを有する適当な緩衝液でよ
い。The buffer may be any suitable buffer having a pH below that of the enzyme.
又、反応温度、反応時間ともに適当な一定条件でよいが
、25〜37℃で30分後に測定するのが望ましい。Further, the reaction temperature and reaction time may be set under appropriate constant conditions, but it is preferable to measure after 30 minutes at 25 to 37°C.
フェノール又はα−ナフトールを測定する方法は従来、
良く知られたガスクロマトグラフィーまたは薄層クロマ
トグラフィー等の物理化学的方法過りロル鉄反応、ジア
ゾカップリング反応、FVB(ファーストバイオレット
Bソルト)法または4アミノアンチピリン法等の化学的
方法のいずれの方法を使用してもよいが、フェノールの
測定の場合、反応液に4−アミノアンチピリンを加え発
色させ分光光度計により吸光度として測定する方法、α
−ナフトールの場合、反応液にFVBを加え発色させ分
光光度計により吸光度として測定する方法がその簡便さ
および検出感度においてより好ましい方法である。Conventional methods for measuring phenol or α-naphthol are:
Either the well-known physicochemical methods such as gas chromatography or thin layer chromatography, or chemical methods such as loriron reaction, diazo coupling reaction, FVB (first violet B salt) method or 4-amino antipyrine method. However, in the case of measuring phenol, 4-aminoantipyrine is added to the reaction solution to develop a color, and the absorbance is measured using a spectrophotometer.
- In the case of naphthol, a method in which FVB is added to the reaction solution to develop a color and measured as absorbance using a spectrophotometer is a more preferable method in terms of simplicity and detection sensitivity.
本性は単一酵素系における測定のみならず種々の酵素が
含まれた場合の測定にも使用できる。This property can be used not only for measurements in a single enzyme system but also for measurements involving various enzymes.
すなわち、例えば血清中に含まれる酵素活性を測定する
場合、血清を適当なプレパラートに添加し、これを電気
泳動等により酵素を分離し、これを本発明物質の溶液に
浸し適当な時間後、更に上記発色試薬を加えることによ
り、従来見ることができなかった血中酵素パターンを見
ることができる。That is, for example, when measuring the enzyme activity contained in serum, the serum is added to an appropriate preparation, the enzyme is separated by electrophoresis, etc., and this is immersed in a solution of the substance of the present invention, and after an appropriate time, further By adding the above-mentioned coloring reagent, it is possible to see enzyme patterns in the blood that were previously impossible to see.
この方法によれば、種々の病態に起因する酵素パターン
の変動を見ることができる。According to this method, changes in enzyme patterns caused by various pathological conditions can be observed.
本発明物質はトリプシン、プラスミン、カリクレイン、
ウロキナーゼ、C1エステラーゼ、スロンビン等種々の
酵素の優れた基質として作用し特にトシルリジン−α−
ナフチルエステルを基質として酵素活性を測定した場合
、従来、酵素基質として知られたトシルリジンメチルエ
ステル、トシルアルギニンメチルエステルを用い、ヘス
テリン法により測定した場合に比べ、14倍ないし25
0倍の検出感度を有していた。The substances of the present invention are trypsin, plasmin, kallikrein,
It acts as an excellent substrate for various enzymes such as urokinase, C1 esterase, and thrombin.
When enzyme activity is measured using naphthyl ester as a substrate, it is 14 to 25 times more active than when measured using the hesterin method using tosyl lysine methyl ester and tosyl arginine methyl ester, which are conventionally known as enzyme substrates.
It had a detection sensitivity of 0 times.
次に実施例をあげ、更に詳細に説明する。Next, examples will be given and explained in more detail.
実施例 l
Na−トシルリジン−α−ナフチルエステルの合成
Na−トシル−N5−カルボベンジルオキシリジン(J
、C,S、、48.30〜34.1957)4.3gを
ピリジン10rrllに溶解し、1,1′−ジナフチル
スルフイツト(Ber、49,2339,1916)3
.5gを加え、室温で3日間かくはんする。Example l Synthesis of Na-tosyl-lysine-α-naphthyl ester Na-tosyl-N5-carbobenzyloxylysine (J
, C, S, , 48.30-34.1957) was dissolved in 10rrll of pyridine, and 1,1'-dinaphthylsulfite (Ber, 49, 2339, 1916) 3
.. Add 5g and stir at room temperature for 3 days.
反応終了後酢酸エチルを加え、希塩酸、飽和重そう水、
飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥
し溶媒を留去する。After the reaction was completed, ethyl acetate was added, diluted hydrochloric acid, saturated deuterated water,
After washing with saturated brine, drying over anhydrous magnesium sulfate and distilling off the solvent.
析出する結晶をエーテルより再結晶するとNa−1−シ
ルーN′ニーカルボベンジルオキシリジン−α−ナフチ
ルエステルが得られる。The precipitated crystals are recrystallized from ether to obtain Na-1-silylN'-nicarbobenzyloxylysine-α-naphthyl ester.
収量5.1g、収率91%これを30%臭化水素酸酢酸
溶液に溶かし室温で30分間かくはんする。Yield 5.1 g, yield 91% This was dissolved in a 30% hydrobromic acid acetic acid solution and stirred at room temperature for 30 minutes.
反応液に無水エーテルを加え結晶状粉末を集め、エタノ
ール、エーテルの混合溶媒より再結晶するとN −トシ
ルリジンα−ナフチルエステル臭化水素酸塩が得られる
。Anhydrous ether is added to the reaction solution, a crystalline powder is collected, and recrystallized from a mixed solvent of ethanol and ether to obtain N-tosyllisine α-naphthyl ester hydrobromide.
収量3.6g、収率50% 融点195〜197℃IR
(KBr)CrrL−’:3250,2950,175
0元素分析 C23H27N2045Br(507,
45)として
理論値 C,5,4,43H,5,36N、5.5
2
実測値 C,54,61H,5,38N、5.64
実施例 2
Na−1−シルリジン−フェニルエステルの合成Na−
)シル−N −カルボベンジルオキシリジン2.1gを
無水エーテル10m1にけんだくし、五塩化リン1.2
gを加えて室温で1時間かくはんする。Yield 3.6g, yield 50% Melting point 195-197℃IR
(KBr)CrrL-': 3250, 2950, 175
0 elemental analysis C23H27N2045Br (507,
45) Theoretical value C, 5, 4, 43H, 5, 36N, 5.5
2 Actual value C, 54,61H, 5,38N, 5.64 Example 2 Synthesis of Na-1-silurisine-phenyl ester Na-
) Suspend 2.1 g of sil-N-carbobenzyloxylysine in 10 ml of anhydrous ether and add 1.2 g of phosphorus pentachloride.
Add g and stir at room temperature for 1 hour.
反応液をろ過し、母液を40℃以下で減圧乾固する。The reaction solution is filtered, and the mother liquor is dried under reduced pressure at a temperature below 40°C.
残渣を無水テトラヒドロフラン1011Llに溶かしフ
ェノール0.47gトリエチルアミン2、1 mlを加
え水冷下1時間かくはんした後室温にもとし1昼夜かく
はんする。The residue was dissolved in 1011 liters of anhydrous tetrahydrofuran, 0.47 g of phenol and 2.1 ml of triethylamine were added, and the mixture was stirred for 1 hour while cooling with water, then brought to room temperature and stirred for 1 day and night.
反応液に酢酸エチルを加え、10%クエン酸、飽和重そ
う水、飽和食塩水で洗浄した後、無水硫酸マグネシウム
で乾燥する。Ethyl acetate was added to the reaction mixture, washed with 10% citric acid, saturated aqueous sodium chloride, and saturated brine, and then dried over anhydrous magnesium sulfate.
溶媒を留去し、残渣をエーテルより再結晶するとNa−
1−シル−N5−カルボベンジルオキ−717ジンフエ
ニルエステルが得られる。When the solvent was distilled off and the residue was recrystallized from ether, Na-
1-Syl-N5-carbobenzyloxe-717 diphenyl ester is obtained.
収i 0−9g1収率38%、融点111〜113°に
れをDMF5Tllに溶解し、ジオキサン塩酸溶液(0
,065gHCl 19 ) 0.8mlおよび10%
Pd−c250IQを加え、室温で3時間水素ガスを通
じる。Yield i 0-9g1 Yield 38%, melting point 111-113° Dissolve the garlic in 5Tll of DMF, dioxane hydrochloric acid solution (0
,065gHCl19) 0.8ml and 10%
Add Pd-c250IQ and pass hydrogen gas through for 3 hours at room temperature.
反応終了後、ろ過し、母液にエーテルを加えるとN
−t−シルリジンフェニルエステル塩酸塩が無色針状晶
として得られる。After the reaction is complete, filter and add ether to the mother liquor to remove N.
-t-silurizine phenyl ester hydrochloride is obtained as colorless needles.
収量0.7g、収率88%、融点117〜120℃IR
(KBr)crfL’;3400,3150.1740
元素分析 C19H25N204SC1(400,8
9)として
理論値 C,56,92H,6,29N、6.99
実測値 C,56,68H,6,31N、6.80
実施例 3
Na−トシルリジン−α−ナフチルエステルを基質とし
たトリジンの活性測定法
トリプシンの希釈液0.511LlにN −)シルリ
ジン−α−ナフチルエステル溶液(0,5μmoles
10.5m5%DMS O) 0.5 mlを加え25
℃で30分間インキュベートする。Yield 0.7g, yield 88%, melting point 117-120℃IR
(KBr)crfL';3400,3150.1740
Elemental analysis C19H25N204SC1 (400,8
9) Theoretical value C, 56,92H, 6,29N, 6.99 Actual value C, 56,68H, 6,31N, 6.80 Example 3 Activity measurement method N-)sillysine-α-naphthyl ester solution (0.5 μmoles
10.5m Add 0.5 ml of 5% DMSO
Incubate for 30 minutes at °C.
これに1%ファーストバイオレットBソルト(FVB)
0.1dを加え0℃で30分間放置し更に氷酢酸ITL
lを加え、発色を吸光光度計により吸光度(515nm
)として測定し、酵素により水解されて遊離したα−
ナフトールを定量する。Add 1% First Violet B Salt (FVB) to this.
Add 0.1d and leave it at 0℃ for 30 minutes, then add glacial acetic acid ITL.
1 and the absorbance (515 nm
), and the α-
Determine naphthol.
この遊離したナフトール量が酵素の活性度である。The amount of liberated naphthol is the activity of the enzyme.
参考例 l
Na−トシルリジンメチルエステルを基質としたトリプ
シンの活性測定法(ヘステリン法)トリフシンの希釈液
(0,5d)にN −)シルリジンメチルエステル溶
液(10μmoles10.4mA’5%DMS O)
0.4TrLl、及びリン酸緩衝液(pH7,4)0
.1mlを加える。Reference example l Trypsin activity measurement method using Na-tosylurisine methyl ester as a substrate (Hesterin method) Trypsin diluted solution (0.5d) with N-) syllysine methyl ester solution (10 μmoles 10.4 mA'5% DMSO)
0.4TrLl, and phosphate buffer (pH 7,4) 0
.. Add 1ml.
37℃で30分間インキュベーションした後、ヒドロキ
シルアミン溶液(2M−NH2OH−HCIおよび3.
5.M NaOHの等景況合物)1.5TLl加え室温
で15分間放置する。After incubation for 30 minutes at 37°C, hydroxylamine solution (2M-NH2OH-HCI and 3.
5. Add 1.5 TLl of M NaOH and leave to stand at room temperature for 15 minutes.
これに18%トリクロル酢酸1ml、4N塩酸1mA’
、及び10%塩化第二鉄1mlを加え充分にかくはんし
た後3000rJ)mで10分間遠心分離する。Add to this 1 ml of 18% trichloroacetic acid and 1 mA' of 4N hydrochloric acid.
, and 1 ml of 10% ferric chloride were added, stirred thoroughly, and centrifuged at 3000 rJ) m for 10 minutes.
上澄液の発色を分光光度計により吸光度(530nm)
として測定する。The color development of the supernatant was measured by absorbance (530 nm) using a spectrophotometer.
Measure as.
この値はトリプシンによって水解されずに残った基質の
量に相関するもので酵素の活性は基質のみの値(対照)
から酵素反応を行なった後に得られる値を引いた値に相
当する。This value correlates to the amount of substrate remaining without being hydrolyzed by trypsin, and the enzyme activity is the value of substrate only (control)
It corresponds to the value obtained by subtracting the value obtained after carrying out the enzyme reaction.
実施例3、及び参考例1で測定したトリプシンの各濃度
段階における結果を第1図に示すが、前者の方法は後者
の方法に比べ約250倍の感度を有していることが分る
。The results at each concentration level of trypsin measured in Example 3 and Reference Example 1 are shown in FIG. 1, and it can be seen that the former method is about 250 times more sensitive than the latter method.
第1図において、○印は実施例3の方法による標準曲線
を、X印は参考例1の方法による標準曲線を示す。In FIG. 1, ○ marks indicate the standard curve obtained by the method of Example 3, and X marks indicate the standard curve obtained by the method of Reference Example 1.
実施例、4
Na−トシルリジンフェニルエステルを基質としたスロ
ンビンの活性測定法
スロンビンの希釈液にN−トシルリジンフェニルエステ
ル溶液(0,5μmoles / 0.5 ml 5%
DMSO) 0.5ml、及び4−アミノアンチピリン
溶液(134m9/200m1リン酸緩衝液)2mlを
加え37℃で30分反応させる。Example 4 Thrombin activity measurement method using Na-tosyllisine phenyl ester as a substrate N-tosyllisine phenyl ester solution (0.5 μmoles / 0.5 ml 5%
Add 0.5 ml of DMSO) and 2 ml of 4-aminoantipyrine solution (134ml/200ml phosphate buffer) and react at 37°C for 30 minutes.
更にフェリシアン化カリウム溶液(500m9/ 20
0rfLlクエン酸緩衝液)2rILlを加え37℃で
30分インキュベーションし、発色を分光光度計により
吸光度(500nm)として測定し酵素により水解され
て遊離したフェノールを定量する。Furthermore, potassium ferricyanide solution (500m9/20
2rILl (0rfLl citrate buffer) is added and incubated at 37°C for 30 minutes, and the color development is measured as absorbance (500 nm) using a spectrophotometer to quantify the phenol released by hydrolysis by the enzyme.
この遊離したフェノール量が酵素の活性度を示す。The amount of released phenol indicates the activity of the enzyme.
実施例 5 電気泳動による血中酵素パターンの測定方法。Example 5 A method for measuring blood enzyme patterns by electrophoresis.
内径4山、長さ7CIrL1のガラス管を用いポリアク
リルアミドゲルカラムを調整する。A polyacrylamide gel column is prepared using a glass tube with four internal diameters and a length of 7 CIrL1.
これに血清40μlを添加し2mAで約50分間泳動し
た後、ゲルを取り出す。After adding 40 μl of serum to this and electrophoresing at 2 mA for about 50 minutes, the gel is taken out.
このゲルを基質溶液(N −トシルリジン−α−ナフ
チルエステル0.5μrnoles/yrtl) 10
mlに浸し、25℃で30分間インキュベーションし
、0℃に冷却した後FVB(ファーストバイオレットB
ソルト)溶液1rnlを加え0℃で30分間放置し、染
色する。This gel was mixed with a substrate solution (N-tosyllysine-α-naphthyl ester 0.5 μrnoles/yrtl) 10
ml, incubated at 25°C for 30 minutes, cooled to 0°C,
Add 1 rnl of solution (salt) and leave at 0°C for 30 minutes to stain.
以上の方法により血中酵素パターンを桃色ないし紫色の
帯状として観察することができる。By the above method, the blood enzyme pattern can be observed as a pink to purple band.
第2図に正常人血清を用いた場合の結果を示す。Figure 2 shows the results when normal human serum was used.
第1図はトリプシン活性の標準曲線を、そして第2図は
血中酵素パターンを示す。Figure 1 shows the standard curve of trypsin activity and Figure 2 shows the blood enzyme pattern.
Claims (1)
り式(I[) で示されるエステル体とし次いでω−アミン保護基を除
去することを特徴とする式(I)(式中Rはフェニル基
、又はα−ナフチル基、R′はアミン保護基を示す) で示されるN 3 式(1) トシルリジン誘導体の製造方法。 (式中Rはフェニル基またはα−ナフチル基を示す) で示さ和るリジン誘導体を基質として酸素と接触させる
ことを特徴とする酵素活性の測定方法。 4 式(I)で示されるリジン誘導体を基質として酵素
と接触させ、一定時間後、酵素により水解されて遊離し
たフェノール、またはα−ナフトールを測定することを
特徴とする特許請求の範囲第3項に記載の酵素活性の測
定法。[Claims] 1. An N-1-silurisine derivative represented by formula (I). (In the formula, R represents a phenyl group or an α-naphthyl group) 2 By subjecting the N tosyl-lysine derivative represented by the formula (Il) and phenol or α-naphthol to a normal dehydration condensation reaction, a compound represented by the formula (I[) is obtained. N3 represented by the formula (I) (wherein R is a phenyl group or an α-naphthyl group, and R' is an amine protecting group) Formula (1) Method for producing tosyl lysine derivative. (In the formula, R represents a phenyl group or an α-naphthyl group.) A method for measuring enzyme activity, which comprises bringing a lysine derivative represented by the following formula into contact with oxygen as a substrate. 4. Claim 3, characterized in that the lysine derivative represented by formula (I) is brought into contact with an enzyme as a substrate, and after a certain period of time, phenol or α-naphthol released by hydrolysis by the enzyme is measured. The method for measuring enzyme activity described in .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12887377A JPS5850986B2 (en) | 1977-10-27 | 1977-10-27 | Lysine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12887377A JPS5850986B2 (en) | 1977-10-27 | 1977-10-27 | Lysine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5463049A JPS5463049A (en) | 1979-05-21 |
JPS5850986B2 true JPS5850986B2 (en) | 1983-11-14 |
Family
ID=14995462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12887377A Expired JPS5850986B2 (en) | 1977-10-27 | 1977-10-27 | Lysine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5850986B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6177287U (en) * | 1984-10-26 | 1986-05-23 | ||
JPS6253193U (en) * | 1985-09-20 | 1987-04-02 |
-
1977
- 1977-10-27 JP JP12887377A patent/JPS5850986B2/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6177287U (en) * | 1984-10-26 | 1986-05-23 | ||
JPS6253193U (en) * | 1985-09-20 | 1987-04-02 |
Also Published As
Publication number | Publication date |
---|---|
JPS5463049A (en) | 1979-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4278763A (en) | Diagnostic agents for the detection of proteolytic enzymes | |
CA1228001A (en) | Composition and test device for determining the presence of leukocytes, containing a zwitterion coupling agent | |
US4645842A (en) | Pyrrole compounds for detecting the presence of hydrolytic analytes | |
US4336331A (en) | Method for assaying the activity of γ-glutamyl transpeptidase in serum | |
JPS60256398A (en) | Compositions and test devices for determining the presence of leukocytes, esterases or proteases in test samples | |
JPS60252464A (en) | Substrates for hydrolase and manufacture | |
US4704460A (en) | Novel compounds for detecting the presence of hydrolytic analytes in a test sample | |
US4209459A (en) | Novel L-leucyl-4-hydroxyanilide derivatives | |
US5750359A (en) | Composition for detecting leucocyte and proteinase in urine and its measuring device | |
JPS631347B2 (en) | ||
IL43735A (en) | Derivatives of gamma-glutamyl-4-nitroanilide and process for the preparation thereof | |
US4379764A (en) | Phenylalanylarginine derivatives, process for producing same and method for measuring activity of enzymes using same | |
US4308202A (en) | Prolylphenylalanylarginine derivatives, process for producing same and method for measuring activity of enzymes using same | |
JPS5850986B2 (en) | Lysine derivative | |
JPS6126917B2 (en) | ||
US4505852A (en) | 7-Amino-4-trifluoromethylquinolone derived substrates and method for determining enzymes and inhibitors | |
JPS6126918B2 (en) | ||
JPS5827784B2 (en) | amino acid derivative | |
US4816562A (en) | Novel substrate for plasma kallikrein and a method for measuring biological components using the same | |
US4774340A (en) | Method for preparing 3-hydroxy pyrroles and esters thereof | |
US6770764B2 (en) | Trypsin substrate and diagnostic device, and method of using same | |
JPH0354938B2 (en) | ||
US4292404A (en) | Method for determining the activity of the angiotensin-converting enzyme | |
US4191809A (en) | Method of measuring enzymatic activity using novel peptide derivatives | |
JPS6112898B2 (en) |